Health Care: Drugs

Cerus Corp (CERS: NASDAQ)

$2.56 0.2 | 8.47%
06/22/17 - 04:00 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 39.27M 34.22M 36.42M 39.66M
Cost of Sales 18.68M 21.97M 19.98M 22.06M
Gross Operating Profit 20.59M 12.26M 16.44M 17.60M
Selling, General, and Administrative Expenses 48.75M 45.99M 37.73M 29.96M
Research & Development 31.32M 25.64M 21.80M 15.19M
Operating Income before D & A (EBITDA) -59.48M -59.38M -43.09M -27.55M
Depreciation & Amortization 1.82M 1.70M 1.42M 745.00K
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net 1.16M 3.24M 6.54M -14.49M
Special Income / Charges -150.00K 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -60.29M -57.83M -37.96M -42.79M
Interest Expense 2.44M 1.71M 599.00K 332.00K
Pre-Tax Income -62.73M -59.54M -38.56M -43.12M
Income Taxes 175.00K -3.67M 195.00K 218.00K
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -62.91M -55.87M -38.76M -43.34M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -62.91M -55.87M -38.76M -43.34M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -62.91M -55.87M -38.76M -43.34M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-62.76M -55.87M -38.76M -43.34M
Preferred Dividends
Net Income Available To Common -62.91M -55.87M -38.76M -43.34M
Basic EPS from Continuing Ops. -0.62 -0.58 -0.52 -0.64
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.62 -0.58 -0.52 -0.64
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.62 -0.58 -0.52 -0.64
Basic Normalized Net Income/Share -0.62 -0.58 -0.52 -0.64
EPS fr Continuing Ops. -0.62 -0.61 -0.61 -0.64
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.62 -0.61 -0.61 -0.64
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.62 -0.61 -0.61 -0.64
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.62 -0.61 -0.61 -0.64
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with CERS

Latest CERS Headlines from TheStreet

More Financial News for CERS

Press Releases for CERS

See All Press Releases

Partner Headlines for CERS

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter